Market
AI Newsfeed
AI Events
AI Agent
Product
Log in
Sign up
Auto Theme
AI News
>
Press Release
Subcutaneous amivantamab delivers promising 45 percent overall response rate with median duration of 7.2 months in recurrent or metastatic head and neck cancer
Gilead to Spotlight New Virology Data Across HIV, Viral Hepatitis and Respiratory Diseases at IDWeek 2025
DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen
Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025
Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025
Genentech's Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer
Typhoon Recovery: U-Haul Offers 30 Days Free Storage across Alaska
Kolibri Global Energy Inc. Provides Update Regarding Information Circular Disclosure
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
FLAGSTAR BANK, N.A. ANNOUNCES COMPLETION OF HOLDING COMPANY REORGANIZATION
StoneX Expands Wealth Management Offering for Latin American Clients
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings
STEP Energy Services Ltd. Agrees to $5.50 Per Share Take Private Transaction With Funds Advised by ARC Financial Corp.
Grindr Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – GRND
ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value As of September 2025
Nabors Energy Transition Corp. II Announces Extension of Its Outside Date
CCH Holdings Ltd Announces Full Exercise of Over-Allotment Option
Univest Securities, LLC Announces Closing of $25 Million Registered Direct Offering for its Client UTime Limited (NASDAQ: WTO)
Fury Files Technical Report for the Eau Claire Gold Project in Quebec
GreenFirst Welcomes the Restart of Operations at One of Its Key Customers, Kap Paper Inc.
Granite REIT Declares Distribution for October 2025
LenderMAC Enters into Strategic Relationship with Ares to Expand Origination and Non-QM Capabilities
FCPT Announces Acquisition of a Heartland Dental Property for $3.3 Million
PFD, PFO, FFC, FLC and DFP Announce Dividends for November
Gyrodyne Announces Agreement with Star Equity Fund
Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.325 PER COMMON SHARE
Credicorp Ltd.: Credicorp's “3Q25 quiet period”
TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps
Humankind Investments Announces Liquidation of the Humankind US Stock ETF
Third Coast Bancshares, Inc. Wins SCI Transaction of the Year
Bank of America Declares Preferred Stock Dividends Payable in November and December 2025
Old Dominion Freight Line Releases 2024 Sustainability Report
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
PINTEC's Subsidiary ZIITECH Makes Its Debut at Tech Week Singapore 2025
FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
GIBO Holdings Limited Announces Transfer to Nasdaq Capital Market
Western Alliance Bank Enters Strategic Alliance with Clover Lending Group to Expand Financing Access for Active Adult Communities
BROAD ARROW'S WYNN LAS VEGAS AUCTION FEATURES SOUGHT-AFTER CARS FOR EVERY COLLECTOR'S TASTE
Organogenesis Holdings Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – ORGO
Suburban Propane with Girl Scouts of Northern New Jersey and the Women in Trucking Association Partner for "Trucks are for Girls: Fueling the Future" Event
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program
Cushman & Wakefield Hires Tony Coskren and Brian Pinch in Boston to Lead Industrial Investment Sales Throughout New England
My List
AI News
AI Events
More